In this episode, Joe interviews the Co-Founders of Tesselate Therapeutics: Dr. Rochelle Hines, Ph.D. (also the CEO and an Associate Professor at UNLV), and Dr. Dustin Hines, Ph.D. (the CSO as well as an Assistant Professor at UNLV).

For decades, mainstream culture has associated psychedelics with impairing the mind rather than improving it. But advocates, researchers and officials are starting to paint a different picture—that substances including magic mushrooms, mescaline, LSD and MDMA can actually help treat serious mental health issues.

Many people with depression, anxiety, or post-traumatic stress disorder (PTSD) benefit from psychedelic drug treatments, clinical trials show. Psychedelic drugs affect thinking, emotion, and perception by binding to and activating the serotonin receptor.

Shadd Dales is joined by career brain researchers and husband-wife team behind Tessellate, a project designed to advance development of mental health psychedelic therapeutics.

Repeated use of small quantities of the psychedelic substance psilocybin can improve mood and mental health, a new study suggests.

As Las Vegas prepares to welcome valleywide cannabis consumption lounges, the state and hopeful licensees are grinding out details of how to safely operate them.

Married couple now run state-of-the-art laboratory in Las Vegas dedicated to advancing psychedelic therapies.

Meet Dr. Rochelle and Dr. Dustin Hines, the husband and wife team trailblazing the future of mental health therapeutics from their lab located at The University of Nevada Las Vegas (UNLV). Both armed with PhD's (University of British Columbia) and extensive post- doctoral training (Tufts University School of Medicine) in neuroscience, Dustin and Rochelle have worked at the interface of academia and industry over their combined 40 plus year careers.